<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"14-3-3 binding protein":1,
"PDZ binding motif":1,
"TAZ (WWTR1)":1,
"epithelial-mesenchymal transition (EMT)":1,
"signal transduction":1,
"stem cell":1,
"Bihar":1,
"fine needle aspiration cytology":2,
"thyroid swelling":1,
"Carcinoma of unknown primary":1,
"Immunohistochemistry":3,
"Molecular profiling":1,
"Triple-negative breast cancer":1,
"insular carcinoma":1,
"thyroid":8,
"DNA repair":1,
"gene polymorphism":1,
"mutation analysis":1,
"Nerve regeneration":1,
"Phonation":1,
"Recurrent laryngeal nerve":1,
"Thyroid neoplasms":11,
"Vocal cords":1,
"Late recurrence":1,
"renal metastasis":1,
"thyroid carcinoma":6,
"Atypical polypoid adenocarcinoma":1,
"Cowden Syndrome":3,
"Endometrial cancer":1,
"Head and neck surgery":1,
"Minimally invasive surgery":1,
"Retropharyngeal lymphadenectomy":1,
"TORS":1,
"Transoral robotic surgery":1,
"F-fluorodeoxyglucose":1,
"differentiated thyroid carcinoma":2,
"iodine-124":1,
"positron emission tomography/computed tomography":1,
"thyroid nodules":1,
"Incidence":2,
"Korea":2,
"Mortality":2,
"Neoplasms":2,
"Survival":2,
"Medullary thyroid cancer":1,
"carcinomatous cirrhosis":1,
"pseudocirrhosis":1,
"Blood type":1,
"Esophageal cancer":1,
"Gastric cancer":1,
"Pancreatic cancer":1,
"Type 2 diabetes":1,
"Bowen disease":1,
"Merkel cell carcinoma":1,
"Esophageal acanthosis":1,
"Gastric polyposis":1,
"Pho-sphatase and tensin homologue mutation":1,
"Thyroid cancer":4,
"BIRC5 protein, human":1,
"Cyclooxygenase 2":1,
"Thyroid cancer, anaplastic":1,
"Thyroid gland":2,
"BRAF":2,
"Peptide nucleic acids":1,
"Thyroid cancer, papillary":2,
"cancer pain":1,
"immunosuppression":1,
"infection":1,
"morphine":1,
"opioid":1,
"oxycodone":1,
"ALK":1,
"EGFR":2,
"adenocarcinoma":1,
"biomarker":1,
"histology":1,
"lung":1,
"micropapillary":1,
"papillary":2,
"pulmonary":1,
"Familial":1,
"HRPT2":1,
"hyperparathyroidism":2,
"parathyroid tumor":2,
"Thyroid, US":1,
"Thyroid, ethanol":1,
"Thyroid, intervention":1,
"Thyroid, nodules":1,
"Thyroid, radiofrequency":1,
"Thyroid, recurrent cancers":1,
"Ionizing radiation, Risk of cancer":1,
"Radiological imaging methods":1,
"Residents":1,
"Breast images":1,
"Lung cancer":1,
"Metastasis":5,
"Micropapillary carcinoma":1,
"Hypopharyngeal carcinoma":1,
"Hypothyroidism":1,
"Laryngeal carcinoma":1,
"Radiotherapy":1,
"Surgery":1,
"Chondroma":1,
"Chondrosarcoma":1,
"Tumours of the larynx":1,
"chrzęstniak":1,
"chrzęstniakomięsak":1,
"guzy krtani":1,
"131I ablation":1,
"Low iodine diet":1,
"Esophagus":1,
"Papillary thyroid cancer":3,
"Excision, pathology":1,
"Granular cell tumor":1,
"Squamous cell carcinoma":1,
"Tongue":1,
"RET":3,
"RET/PTC":2,
"oncogene":1,
"Intramedullary spinal cord tumor":1,
"Spinal cord apoplexy":1,
"Central compartment of the neck":1,
"Charcoal tattoo":1,
"Differentiated thyroid cancer recurrence":1,
"Surgical complications":1,
"Follicular carcinoma of thyroid":1,
"mandible":1,
"Cytokeratin 19":1,
"follicular adenoma":1,
"multinodular goitre":1,
"papillary thyroid carcinoma":7,
"Adenoma":1,
"Carcinoma":2,
"Parathyroid":1,
"Parathyromatosis":1,
"Positron-emission tomography":1,
"Thyroid nodule":3,
"renal cell":1,
"depletion syndrome":1,
"exercise intolerance":1,
"fatigue":1,
"genetics":1,
"mitochondrial DNA":1,
"polysomnia":1,
"Chromosome rearrangements":1,
"Receptor tyrosine kinase":1,
"Tyrosine kinase inhibitors":1,
"Meningioma":1,
"Primary Hyperaldosteronism":1,
"Thyroid Cancer, Hürthle-cell":1,
"Incidentaloma":2,
"Magnetic resonance angiography":1,
"Neoplasm":1,
"Ultrasonography":1,
"ime-resolved":1,
"Gene expression profiling":1,
"Microarray":1,
"Deletion":1,
"Korean":1,
"Mutant enrichment with 3'-modified oligonucleotides (MEMO) PCR":1,
"Mutation":2,
"Carney complex":1,
"Pendred syndrome":1,
"Werner syndrome":1,
"familial adenomatous polyposis":1,
"familial papillary thyroid carcinoma":1,
"familial thyroid carcinoma":1,
"Hypercalcemia":1,
"Polycythemia vera":1,
"Follicular carcinoma thyroid":1,
"Multinodular goiter":1,
"Palliative treatment":1,
"Well-differentiated carcinoma":1,
"Glandular differentiation":1,
"Mediastinum":1,
"Mucin":1,
"Thymoma":2,
"CK19":1,
"D2-40":1,
"VEGF":1,
"galectin-3":1,
"immunohistochemis":1,
"papillary carcinoma":2,
"carcinoma, papillary":1,
"wild-type p53-induced phosphatase 1":1,
"Apoptosis":1,
"Curcumin":1,
"Mitochondrial membrane potential":1,
"Papillary thyroid cancer cell line K1":1,
"Reactive oxygen species":1,
"Exercise-induced arrhythmia":1,
"MEN syndrome":1,
"Child":1,
"Lung metastases":1,
"Parathyroid carcinoma":1,
"Biopsy":1,
"Skull metastasis":2,
"L-thyroxine":1,
"TSH suppression":1,
"pregnancy":1,
"Adenocarcinoma in situ":1,
"Neoplasm metastasis":3,
"Tumor-to-tumor":1,
"Biopsy, fine-needle":1,
"Cytodiagnosis":1,
"Thymus gland":1,
"Cardiac metastasis":1,
"Gallbladder carcinoma":1,
"Malignant pericardial effusion":1,
"Gossypiboma":1,
"Neck surgery":1,
"Surgical sponge":1,
"breast carcinoma":1,
"mucinous carcinoma of the skin":1,
"anaplastic":1,
"cancer":4,
"genetic alteration":1,
"prognosis":3,
"therapy":1,
"treatment":1,
"tumor":1,
"ATP-CRA":1,
"Chemotherapy Drugs":1,
"Hormonal Therapy Drugs":1,
"Refractory Thyroid Carcinoma":1,
"Thyroid Carcinoma Cell Lines":1,
"Follicular thyroid carcinoma":3,
"radioiodine ablation":1,
"Absorbed dose":1,
"Monte Carlo N particle":1,
"medical internal radiation dosimetry":1,
"phantom":1,
"radioiodine therapy":1,
"thermoluminescent dosimeter":1,
"radio iodine":1,
"thyroid malignancy":1,
"Diagnosis":1,
"Fine needle aspiration":2,
"Sperm-associated antigen 9":1,
"vandetanib":2,
"Benefit assessment":2,
"Chronic Lymphocytic Thyroiditis":1,
"Prognostic Outcome":1,
"Recurrence":2,
"Hypocalcemia":1,
"Parathyroid glands":1,
"Thyroidectomy":2,
"Lung neoplasms":1,
"breast neoplasm":1,
"Prevalence":2,
"Thyroglobulin":1,
"Elevated Thyroglobulin Levels":1,
"Negative [131I] Whole-Body Scan":1,
"PET/CT":1,
"[124I]-PET":1,
"[18F]-FDG-PET":1,
"Hashimoto thyroiditis":1,
"microRNA":1,
"Cystic papillary carcinoma":1,
"Partially cystic nodule":1,
"Partially cystic papillary carcinoma":1,
"Ultrasound":1,
"Glioblastoma":1,
"Magnetic resonance imaging":1,
"Radiation induced glioma":1,
"Rhabdomyosarcoma":1,
"Spinal cord":1,
"Lymph node":1,
"VEGF-A":1,
"VEGF-C":1,
"Anaplastic carcinoma of thyroid":1,
"difficult tracheostomy":1,
"fiberoptic bronchoscope":1,
"18F-Fluorodeoxyglucose":1,
"Autoimmune thyroid disease":1,
"Diffuse thyroid uptake":1,
"Positron emission tomography":1,
"Familial non medullary thyroid carcinoma":1,
"Iran":1,
"loss of heterozygosis":1,
"thyroid tumor with oxyphilia cell":1,
"Benign":1,
"Guidelines":1,
"Microcarcinoma":1,
"MAPK/ERK":1,
"PI3/Akt":1,
"RAF":1,
"RAS":1,
"kinase inhibitors":1,
"Lymphatic metastasis":1,
"Observation":1,
"Compression fracture":1,
"Spinal metastasis":1,
"Lymph node metastasis":1,
"Renal cell carcinoma":1,
"Unknown primary cancer":1,
"Without primary site":1,
"Bone Scintigraphy":1,
"Bone Secondarisms":1,
"Neoplastic Hypercalcemia":1,
"Osteolysis":1,
"Parathyroid Adenoma":1,
"Primary Hyperparathyroidism":1,
"BCPAP":1,
"FTC133":1,
"TPC1":1,
"WRO":1,
"cell line":1,
"Clinicopathologic Characteristics":1,
"Single Nucleotide Polymorphisms":1,
"Toll-Like Receptors":1,
"Age":1,
"Acute urticaria":1,
"Thyroid papillary carcinoma":1,
"Breast neoplasms":1,
"Human MUC1 protein":1,
"Human MUC6 protein":1,
"Mucins":1,
"endobronchial ultrasound-guided transbronchial needle aspiration, sarcoidosis, mediastinal and hilar lymphadenopathy, lymph node metastasis":1,
"Healthcare System":1,
"Overdiagnosis":1,
"Public Health Expenditure":1,
"Methylation":1,
"RUNX3":1,
"Iodine radioisotopes":1,
"Anemia":1,
"Outpatient clinic":1,
"binasal":1,
"endoscopic approach":1,
"pituitary":1,
"sella":1,
"Cervix uteri":1,
"Muscle, skeletal":1,
"Neoplasms, squamous cell":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2012年论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
